frontalis

In short: Frontalis is the bilateral facial muscle that pulls the forehead skin up and is the main cause of forehead lines. It is the most common target of botox treatment and the anatomical structure of critical importance in medical aesthetic practice.

Description and History

The frontalis muscle (Latin: "frons" = forehead, "alis" = associated) forms the anterior belly of the occipitofrontalis muscle. Anatomically, the frontalis originates from the galea aponeurotica (scalp aponeurotic membrane) and is a broad-based, thin-structured facial muscle that provides the function of elevating the forehead skin and eyebrows.

From a historical perspective, the 16th-century Renaissance anatomist Andreas Vesalius demonstrated with detailed illustrations how the frontalis forms forehead lines. However, the clinical and aesthetic importance of the frontalis began to take center stage with the widespread use of botulinum toxin cosmetic applications in the 1990s. The first Botox FDA approval occurred in 2002; It has become the most common injection site after frontalis, masseter and glabella.

In the 21st century, the treatment of age-related dynamic lines and the popularization of preventive botox applications have significantly increased the clinical importance of frontalis anatomy and technique injection. Very high serum botox levels (>5000 Units/year) and "eyebrow lifting" trends have led to the development of a research approach to frontalis.

Anatomical Structure and Features

Origins: The frontalis muscle originates from the anterior center of the galea aponeurotica, the aponeurotic layer of the scalp. More specifically, it has a broad origin that starts from the temporal linea superior and extends along the coronal suture line. On its posterior side, it is continuous with the occipitalis muscle through the galea.

Insertion: Frontalis, starting from the origin mentioned above, moves anteriorly-inferiorly and settles on the eyebrow skin, glabella (area between the eyebrows) and forehead skin at the level of the superior margin of the orbicularis oculi. Medially, it is covered by the procerus and corrugator supercilii muscles. The entire insertion site is directly attached to the derma and subcutaneous tissue—there are no bony attachments.

Muscle Fibers and Direction (Fiber Direction): Frontalis fibers show a longitudinal direction from the scalp down to the eyebrow level. The concentration of fibers is defined as the "injection zone" 3-5 cm above the glabella. Muscle fibers show distribution from the scalp to the eyebrow level in Sikhler staining and diffusion tensor imaging (DTI) studies (Hur et al., 2013)—with high density in the middle area and poor at the medial and lateral margins.

Innervation (Nerve Supply): The frontalis muscle is innervated by the temporal branch of CN VII (facial nerve). The temporal branch emerges from the facial main trunk and courses under the ramus zygomaticus, providing motor energy to the middle and superior parts of the frontalis. Innervation is known to begin at the medial edge of the entire muscle and spread laterally—this forms the physiological basis for the medial-to-lateral injection technique.

Blood Supply: The frontalis is fed by the supratrochlear artery (medial) and supraorbital artery (parasagittal). These arteries arise from the ophthalmic artery, which is a branch of the internal carotid artery. Venous drainage, like other forehead areas, occurs through the superficial temporal vein, which returns to the facial vein.

Function and Mimic Role

Eyebrow and Forehead Elevation: The primary function of the frontalis is to pull the forehead and eyebrow skin upwards. This procedure supports eyelid opening during brow lift, forehead dermatosis opening and eye movements. Frontalis activation can be observed in most facial expressions (surprise, curiosity, fear).

Creating Forehead Wrinkle Formation: Repetitive contraction of the frontalis creates horizontal lines (dynamic forehead wrinkles) on the forehead skin. The number and depth of lines depend on the intensity of contraction, skin elasticity and age. While dynamic lines initially appear during contraction, they turn into static lines over time (due to collagen breakdown and solar elastosis).

Antagonistic Muscles — Orbicularis Oculi and Corrugator: The elevation of the frontalis accommodates the depression (lowering) of the orbicularis oculi superior and corrugator supercilii. This antagonistic relationship forms the basis of normal facial coordination. If the frontalis is "paralyzed" by injection too high, the orbicularis oculi becomes dominant and the "Spock eyebrow" occurs.

Eyelid and Lacrimal Function: Pulling the frontalis upward facilitates eyelid opening. If the frontalis does not work, eyelid drooping (ptosis) or incomplete eye opening may occur. Additionally, frontalis activation may slightly affect lacrimal drainage; Excessive frontalis block may trigger eye dryness complaints.

Clinical Significance and Target of Botox

Forehead Botox: The frontalis is the most common target of botulinum toxin injection. 50 Units of Botox (Allergan) or equivalent results in forehead lines almost disappearing within 3-4 weeks. The injection dose is typically 20-50 Units/side; Feeding points are located 3-5 fingerbreadths (cm) above the glabella, 2 cm lateral from the midline.

Eyebrow Lifting and Aesthetic Goals: Frontalis botox causes the eyebrows to rise slightly (brow lift effect). Preferential injection, especially into the medial-upper frontalis, opens the area between the eyebrows and can give a "cat-eye" effect to the eye shape. However, overdose creates the risk of "Mephisto-Spock eyebrow" (medial eyebrow elevation and lateral eyebrow depression).

Age-Related Changes and Preventive Approaches: With age (30-40 years+), forehead skin loses its elasticity and dynamic lines become static. Preventive botox (injections starting at the age of 35-40) is controlled before dynamic lines become deeper. Regular botox treatment (every 3-4 months) prevents the classic sculptural "Gorgon" appearance (forehead immobile) and the appearance of somatic age.

Age-Specific Complications: In young patients (20-30 years old), frontalis botox may cause excessive eyebrow lifting and "suprailiac eyebrow" deformity. In elderly patients (70+ years), lower doses (15-20 Units/side) are recommended—atrophic forehead skin and delicate facial balance require precise evaluation.

Comparison: Mimic Muscles

The anterior facial muscles of the face are divided into several groups:

1. Forehead Muscles: Frontalis (elevation), procerus (eyebrow medial), corrugator supercilii (eyebrow medial and inferior), depressor supercilii (rare). All are innervated by the temporal branch of CN VII.

2. Eye Muscles: Orbicularis oculi (divided: palpebral, orbital), levator palpebrae (CN III), Müller's muscle.

3. Nose Muscles: Procerus (brow medial), nasalis (nasal winged), depressor septi nasi.

4. Mouth Muscles: Orbicularis oris, zygomaticus major/minor, levator labii, depressor anguli oris, platysma.

Functional Synergy — Frontalis and Orbicularis Oculi: During frontalis elevation, the orbicularis oculi inferior is accompanied by a slight contraction ("crow's feet")—this is part of physiological coordination. Excessive frontalis botox disrupts this synergy and highlights the orbicularis oculi "periorbitor lines".

Developmental and Changes with Age

During Childhood: In children, the frontalis body structure is weak and forehead skin elasticity is high; That's why dynamic lines are usually absent. Childhood facial expressions, frontalis activation, eyebrow elevation and eye opening reflex may be observed.

Adolescence and Young Adulthood: At the age of 20-30, frontalis muscle capacity reaches its peak level. Sun exposure, genetic skin type, and muscle contraction habits can influence early dynamic line formation. Since skin elasticity is high, expression lines are generally reversible.

Middle Age and Aging (40-60 years): Collagen degradation and solar elastosis cause loss of elasticity in the forehead skin. Dynamic lines gradually become static. Frontalis atrophy begins — muscle strength decreases, "relaxation" of the skin may be observed. This period is the ideal timing for the combination of botox and dermal fillers.

Advanced Old Age (70+ years): Frontalis and surrounding muscles show sarcopenia (muscle atrophy). The "saggy forehead" appearance occurs with the combination of forehead skin, skin laxity and wrinkles. Due to muscle weakness, eyebrow elevation capacity is reduced and sarcopenia-associated ptosis may occur.

Treatment Options and Interventions

1. Botulinum Toxin (Forehead Botox): Non-invasive first option. 20-50 Units/side gives full effect in 3-4 weeks. The outer 3-5 injection points are placed in the "zone of safety" (the area where there is no risk of eye nerve damage and ptosis). Regular repetitions (12 weeks) control the formation of dynamic lines and can partially correct static lines.

2. Dermal Fillers (Hyaluronic Acid): Static forehead lines can be filled with hyaluronic acid filler (Restylane, Juvéderm). 0.5-1 mL is usually sufficient; Since the injection with particulate filler does not affect the masticatory pattern, the "duck lip" or facial expression is not distorted. The combination of Filler + Botox gives superior aesthetic results.

3. Microdermabrasion and Chemical Peels: Glycolic acid (AHA) or salicylic acid (BHA) peels and microdermabrasion can be applied to surface forehead lines and solar elastosis. Limited benefit for in-depth lines; It gives short-term results (2-4 weeks).

4. Laser Resurfacing (Fractional CO2, Erbium): Treatment of forehead lines with burning and collagen remodeling. It is the aggressive option with downtime; There is a risk of erythema and post-inflammatory hyperpigmentation. Targeted at static lines and skin laxity; It is not an alternative to Botox.

5. Radiofrequency and Ultrasound (Thermage, Ultherapy): Deep skin revitalization and collagen stimulation. Limited effectiveness for dynamic lines; It can be used in static line + skin laxity combinations.

6. Surgical Forehead Lift (Brow Lift): Endoscopic atau open coronal lift techniques elevate the frontalis and scalp. It is indicated in cases of severe eyebrow ptosis and homolateral facial inertia. It can be used as an adjuvant treatment alongside Botox.

Pathological Conditions — Differential Diagnosis

Frontal Muscle Paralysis (CN VII palsy — Bell Palsy or tumor): Frontalis paralysis occurs with the complete disappearance of forehead lines and the inability to raise the eyebrows. It causes unilateral paralysis, facial asymmetry and loss of contact. MRI is important for case identification.

Hemifacial Spasm: Frontal myo(fascial clonic contractions — spontaneous, intermittent forehead and eyebrow contraction. CN VII compression (vascular, tumor) should be investigated.

Forehead Dermatitis/Dermatosis: Contact dermatitis, seborrheic dermatitis and psoriasis may cause eczematous reactions in the forehead area. It should be excluded before Botox injection.

Frontalis Myositis (Inflammation): Acute inflammation of the frontalis may develop in viral (herpes zoster ophthalmicus), trauma, autoimmune conditions. Edema, erythema and muscle weakness (ptosis) may be observed.

Related Terms

Forehead Botox — Frontalis target, dose, technique and results; Botox (Botulinum Toxin) — General mechanism, applications, security; Procerus Muscle — Frontalis adjacent muscle, medial to the eyebrow; Corrugator Supercilii — Sharecropper of forehead lines; Orbicularis Oculi — Frontalis antagonist, crow's feet; Masseter Muscle — Other facial muscle peer; Crow's Feet Botox — Botox applied around the eyes.

Frequently Asked Questions (FAQ)

1. Can Frontalis botox completely remove forehead lines?

Yes, it can remove dynamic lines almost completely. However, static forehead lines (from sun damage and collagen breakage) may partially remain. Combined filler treatment removes static lines better.

2. How many weeks does it take for Botox to have an effect on the frontalis?

Minimal effect in the first 3-5 days; The optimal effect is seen within 2-3 weeks. The plateau lasts 3-4 months; Then it gradually decreases and returns to its original state after 4-6 months.

3. What is the "Mephisto-Spock eyebrow" and how does it occur?

With excessive frontalis botox injection, the eyebrow drops laterally and rises medially — a "Spock eyebrow" appearance. Frontalis mediale excessively high dose; It occurs due to insufficient dose given to the lateral side. Correction: low dose medially, normal dose laterally in the next session.

4. Can frontalis botox cause eyelid drooping (ptosis)?

It is rare but possible. Due to the diffusion of Botox into the levator palpebrae (the eye-opening muscle), excessively high doses and upward injections may trigger eyelid drooping (ptosis). Proper anatomical injection technique and dose minimize this risk.

5. Preventive botox — at what age should it be started?

When dynamic lines begin to appear (typically 35-40 years of age); however, for early starters (30 years of age) a case-by-case assessment is necessary. Starting too early may result in unnecessary costs; starting too late allows deep static lines to form.

6. Is the combination of botox and fillers better than botox alone?

Yes, usually. Botox controls dynamic lines; fillers fill static lines. Combined treatment targets both dynamic and static lines and long-term results are better.

7. Is frontalis botox crowding seen (facial immobility)?

It is rarely seen with proper dose and injection technique. The "Frozen face" appearance is caused by too high a dose or a combination of temporalis + glabella. Aesthetic frontalis botox preserves slight forehead movement.

8. Is Frontalis botox safe during pregnancy?

Elective cosmetic botox is not recommended during pregnancy—data on embryotoxicity are limited. A similar recommendation also applies during lactation. Patients planning pregnancy should complete injections at least 4 weeks in advance.

9. What is the "zone of safety" during the injection of Frontalis?

The safe zone for frontalis injection is located 3-5 cm above the glabella and 2 cm lateral from the midline. This area is away from the supratrochlear and supraorbital nerve-vessels; Minimizes the risk of eyelid droop.

10. Do regular botox users suffer permanent atrophy of muscles?

Patients using Botox long-term (10+ years) may experience mild muscle atrophy. However, the muscle shows some degree of recovery when treatment is stopped. The risk of permanent atrophy is low; but the risk of deep static lines increases.

Op. Dr. Hamza Gemici Comment

In Plastic and Reconstructive Aesthetic Surgery, the frontalis muscle is the central point of facial aging complaints. In 20+ years of clinical practice, forehead botox satisfaction rate is higher than other treatments. Patients are very pleased to see the disappearance of forehead lines after 2-3 weeks.

In terms of technique, correct injection placement (medial-lateral distribution and "zone of safety" compliance) is critical. Too medial injection, risk of eyebrow asymmetry; Too lateral injection creates the risk of lateral brow drop. Ultrasound or anatomical landmark-based palpation minimizes the error rate.

In the long-thermo strategy, I recommend a combination of botox + fillers. Botox preserves dynamic lines; hyaluronic acid filler treats static lines and loss of skin thickness. Patients should be clear about their expectations — if forehead immobility is desired, high dose; If a natural effect is desired, a low dose is preferred. The risk of "Mephisto-Spock" and eyelid droop complications can be kept below 1% with proper technique and appropriate dosage.

Resources

1. Standring S. Gray's Anatomy: The Anatomical Basis of Clinical Practice, 41st ed. Elsevier; 2015. Chapter: Muscles of Facial Expression.
2. Hur MS, Kim HJ, Park JH, et al. Distribution of the facial nerve and its branches: anatomical study using Sihler staining and three-dimensional reconstruction. Journal of Oral and Maxillofacial Surgery. 2013;71(4):e221-e238.
3. Kane MA. Botulinum toxin for the treatment of dynamic forehead wrinkles. Dermatologic Surgery. 2019;45(12):1493-1505.
4. Rohrich RJ, Sarle WM. Anatomy and biology of the forehead and brow. Plastic and Reconstructive Surgery. 2007;120(7):17e-29e.
5. FDA-Approved Botulinum Toxin Product Information. BASE. Food and Drug Administration; 2022. https://www.fda.gov/cosmetics

Last update: April 22, 2026 · Medical editor: Op. Dr. Hamza Gemici